White Paper: The Cost of Quality in the Specialty Pharmaceutical Supply Chain

By Ruediger Lomb

Quality vs Expenditure: Are you willing to risk it all? 

As R&D focus shifts towards high-precision, low-volume therapies comprising of expensive and sensitive shipments, what are the repercussions of a temperature excursion or delayed delivery? The impact can be broad and far-reaching, resulting in compounded inefficiencies and increased costs throughout the entire pharmaceutical chain, ultimately affecting the patient relying on timely treatment.

Discover how to create a new quality mindset which enables not only a more robust management system, but can add value for your organization and generate better patient outcomes. 

To download your copy, please enter your details in the form below 


About the Author

Ruediger Lomb

Vice President, Enterprise Quality Assurance, International Operations
AmerisourceBergen Global Commercialization Services & Animal Health
View Bio